F-18 Fludeoxyglucose Unit Dose radiopharmaceuticals

The Department of the Army Medical Command is seeking FDA-approved radioisotope providers to supply F-18 Fludeoxyglucose (FDG) unit dose radiopharmaceuticals to the Dwight David Eisenhower Army Medical Center (DDEAMC) Department of Nuclear Medicine at Fort Gordon, Georgia. The contractor must possess FDA approval as a radioisotope provider and be capable of providing all necessary personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and services for preparation and delivery of the products. Key contract requirements include delivering each unit dose containing 10-15 mCi of F-18 FDG at time of calibration with direct delivery to the DDEAMC Nuclear Medicine Department no less than 30 minutes prior to calibration time. This is a Sources Sought Notice for market survey purposes only, not a formal solicitation, meaning no contract will be awarded from this announcement. Interested parties must submit a written Statement of Capability limited to 5 pages by May 7, 2026, at 1:00 P.M. Central Standard Time via email to Wayne Shavers at wayne.shavers.civ@health.mil, with all businesses required to be registered in the System for Award Management (SAM).

This opportunity does not utilize any set-aside designations, though the government is actively seeking responses from small businesses including 8(a), HUB-Zone, Women-Owned Small Business, and Service-Disabled Veteran-Owned Small Business entities, as well as large businesses. The anticipated contract type is Firm Fixed Price, though no specific award value or budget range is disclosed in this pre-solicitation notice. The government is seeking to procure an estimated 450 unit doses of FDA-approved F-18 FDG radiopharmaceuticals, with no mention of current incumbents or existing contractors provided. The NAICS code 325412 (Pharmaceutical Preparation Manufacturing) applies to this procurement, which falls under PSC Category 6515 (Medical and Surgical Instruments, Equipment, and Supplies). No reimbursement will be provided for response costs, no subcontracting opportunities are anticipated, and the government is not obligated to issue a solicitation or award a contract based on this notice.